We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$367M
AUM Growth
-$15.4M
Cap. Flow
-$423K
Cap. Flow %
-0.12%
Top 10 Hldgs %
41.26%
Holding
60
New
5
Increased
26
Reduced
17
Closed
3

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$10.9M
2
ALLE icon
Allegion
ALLE
+$6.16M
3
HSIC icon
Henry Schein
HSIC
+$2.93M
4
FISV
Fiserv Inc
FISV
+$2.47M
5
EXPE icon
Expedia Group
EXPE
+$2.42M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$10.4M
2
UNVR
Univar Solutions Inc.
UNVR
+$9.07M
3
VMW
VMware, Inc
VMW
+$4.54M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.83M
5
RTX icon
RTX Corp
RTX
+$1.86M

Sector Composition

Rank Sector Weight
1 Technology 25.4%
2 Healthcare 19.61%
3 Financials 14.31%
4 Consumer Staples 14.3%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
51
Novartis
NVS
$293B
$1.05M 0.29%
10,290
-102,752
-91% -$10.4M
KHC icon
52
Kraft Heinz
KHC
$31.1B
$620K 0.17%
18,418
PG icon
53
Procter & Gamble
PG
$338B
$515K 0.14%
3,532
XOM icon
54
ExxonMobil
XOM
$644B
$374K 0.1%
3,183
IMXI icon
55
International Money Express
IMXI
$373M
$341K 0.09%
20,140
+4,721
+31% +$95K
NSP icon
56
Insperity
NSP
$2.02B
$268K 0.07%
2,747
WEX icon
57
WEX
WEX
$6.42B
$265K 0.07%
+1,410
New +$272K
INMD icon
58
InMode
INMD
$881M
-6,204
Closed -$232K
SPNS
59
DELISTED
Sapiens International
SPNS
-12,325
Closed -$328K
UNVR
60
DELISTED
Univar Solutions Inc.
UNVR
-253,010
Closed -$9.07M

Similar funds

Foyston, Gordon, & Payne's Q3 2023 Portfolio in Review

As of Q3 2023, Foyston, Gordon, & Payne held 60 positions worth $367M, down 4% from $382M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foyston, Gordon, & Payne's Q3 2023 filing shows 5 new, 26 increased, 17 reduced and 3 closed positions. Its largest new stake was Kenvue: 472,720 shares worth $9.49M. The largest sale was Novartis, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Foyston, Gordon, & Payne's largest Q3 2023 buy was Kenvue: 472,720 shares worth $9.49M.
  • Foyston, Gordon, & Payne added most to Fiserv Inc in Q3 2023, an estimated $2.47M increase.
  • Foyston, Gordon, & Payne's biggest Q3 2023 reduction was Novartis, cutting an estimated $10.4M.
  • Foyston, Gordon, & Payne fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $9.07M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 41% of its $367M portfolio in Q3 2023.
  • Foyston, Gordon, & Payne opened 5 new positions and closed 3 in Q3 2023.
  • Foyston, Gordon, & Payne's portfolio value fell 4% quarter-over-quarter to $367M.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2023, filed 26 Oct 2023.